TrumpXi Summit Two Tech Flashpoints That Could Define the Outcome Bronstein Gewirtz Grossman Files Class Action Lawsuit Against Hercules Capital Inc Investors Urged to Act Bond Yields Reach OneYear High Amid Oil Price Surge and Inflation Concerns Tom Lees BitMine Scoops Up 151M in Ethereum During Market Downturn Utssav CZ Gold Jewels Hits AllTime High After FY26 Profit Surge Bucking Market Trend Walmart CFO Notes Consumer Stress as Shoppers Reduce Gas Purchases to Under 10 Gallons Amazon Taps Amwell CoFounder as New Health Chief as Top Exec Departs Trump Seeks Supreme Court Intervention to Delay TikTok Ban Treasury Yields Mixed as New Fed Chair Kevin Warsh Takes Office Amid Persistent Bond Volatility SpaceXs Starship V3 Test Flight Marks Major Milestone for Space Industry Ethos Technologies Inc LIFE Q1 2026 Earnings EPS Surges 138 Above Estimate Yet Stock Declines Sharply BN Q1 2026 Earnings EPS Surpasses Estimates Amid Slight Stock Decline MasTec MTZ Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction FB Financial Q1 2026 Earnings Slight EPS Miss Meets Modest Stock Gains BIPC Q1 2026 Earnings Wide Earnings Miss on Significant EPS Shortfall CBRL Q1 2026 Earnings Profitability Surprise as EPS Crushes Estimates Ultragenyx RARE Edges Lower as Resistance Holds Support Levels Eyed Plum Acquisition Corp IV Unit PLMKU Holds Steady at 1088 as Market Awaits Catalyst 51Talk COE Holds Steady Near Support Consolidation Phase in Focus Clean Energy Fuels Corp CLNE Edges Higher Amid Sector Dynamics Heritage Commerce Corp HTBK Holds Steady at 1345 as Key Levels Loom Belden Inc BDC Faces Selling Pressure Testing Key Support Levels Fastenal FAST Edges Higher Amid Steady Volume Testing Key Resistance Levels Howmet Aerospace HWM Gains 164 as Aerospace Demand Lifts Shares Toward Resistance CGABL Holds Steady Near Key Support Amid Low Volume Vista Gold Corp VGZ Posts Modest Gain as Shares Hold Support Near 213 Preah Vihear Temple Clashes Raise Concerns for World Heritage and Regional Stability ZYME Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Reports Wider Loss SELLAS Life Sciences SLS Rises 291 as Support Holds Above 739